Surgepays Inc (NASDAQ: SURG) stock jumped 10.47% on Friday to $5.91 against a previous-day closing price of $5.35. With 0.57 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.12 million shares. During the session, the Software – Application company that operates in wider Technology sector, reached to the highest price of $5.94 whereas the lowest price it dropped to was $5.45. The 52-week range on SURG shows that it touched its highest point at $8.33 and its lowest point at $3.88 during that stretch. It currently has a 1-year price target of $13.00. Beta for the stock currently stands at 1.52.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SURG was up-trending over the past week, with a rise of 13.87%, but this was up by 26.82% over a month. Three-month performance surged to 15.43% while six-month performance fell -4.06%. The stock gained 16.11% in the past year, while it has lost -9.91% so far this year. A look at the trailing 12-month EPS for SURG yields 1.41 with Next year EPS estimates of 1.74. For the next quarter, that number is 0.34. This implies an EPS growth rate of 2860.00% for this year and 25.72% for next year.

Float and Shares Shorts:

At present, 14.12 million SURG shares are outstanding with a float of 8.52 million shares on hand for trading. On Oct 30, 2023, short shares totaled 1.5 million, which was 10.52% higher than short shares on Sep 28, 2023. In addition to Mr. Kevin Brian Cox as the firm’s Chairman & CEO, Mr. Anthony George Evers CPA, CIA, CPA serves as its CFO & Acting COO.

Institutional Ownership:

Through their ownership of 12.32% of SURG’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 7.69% of SURG, in contrast to 40.09% held by mutual funds. Shares owned by individuals account for 4.93%. As the largest shareholder in SURG with 3.29% of the stake, The Vanguard Group, Inc. holds 468,685 shares worth 468,685. A second-largest stockholder of SURG, PRAETORIAN PR LLC, holds 450,000 shares, controlling over 3.16% of the firm’s shares. Myda Advisors LLC is the third largest shareholder in SURG, holding 244,267 shares or 1.72% stake. With a 2.43% stake in SURG, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 345,312 shares are owned by the mutual fund manager. The Bridgeway Ultra Small Company Fun, which owns about 0.80% of SURG stock, is the second-largest Mutual Fund holder. It holds 113,158 shares valued at 0.49 million. Vanguard Extended Market Index Fu holds 0.78% of the stake in SURG, owning 110,873 shares worth 0.48 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SURG since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SURG analysts setting a high price target of $15.00 and a low target of $11.00, the average target price over the next 12 months is $13.00. Based on these targets, SURG could surge 153.81% to reach the target high and rise by 86.13% to reach the target low. Reaching the average price target will result in a growth of 119.97% from current levels.

Summary of Insider Activity:

Insiders traded SURG stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 6 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 1,150,200 while 0 shares were sold.

Leave a Reply

Your email address will not be published. Required fields are marked *